1 completed, 1 not yet recruiting, 1 recruiting. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Enoxaparin 40 mg: new trials by email Literature Review of Enoxaparin 40 mg trials Research Report on Enoxaparin 40 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis Outcomes Rivaroxaban, Enoxaparin 40 mg - Postpartum Period, Cesarean Section Surgery | Not applicable | Recruiting | Wolfson Medical Center | 62 | 2025-12-01 | 2026-09-15 |
| Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome Edoxaban 60 mg, Enoxaparin 40 mg - Nephrotic Syndrome, Hypoalbuminemia | Not applicable | Not yet recruiting | Peking University People's Hospital | 60 | 2025-09-01 | 2025-08-11 |
| A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery JNJ-70033093 25 mg, JNJ-70033093 50 mg, JNJ-70033093 100 mg - Arthroplasty, Replacement, Knee | Phase 2 | Completed | Janssen Research & Development, LLC | 1242 | 2019-06-17 | 2025-03-30 |
Hypoalbuminemia (1) · Nephrotic Syndrome (1) · Venous Thromboembolism (1)
Janssen Research & Development, LLC (1) · Peking University People's Hospital (1) · Wolfson Medical Center (1)
Israel (2) · Argentina (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Greece (1) · Hungary (1) · Italy (1) · Japan (1) · Poland (1) · Portugal (1) · Russia (1) · South Africa (1) · Spain (1)
Amihai Rottenstreich, MD (1) · Hagit Eisenberg, MD (1) · Ilia Kleiner, MD (1) · Noa Gonen, MD (1)
PMID 15234649, PMID 15811953, PMID 21900088, PMID 22315257, PMID 23013426, PMID 25940537, PMID 27126650, PMID 34780683, PMID 38038437
2018 (1)